Categories
Business

Airline CEOs ramp up stress on governments to open up U.S., U.Ok. journey

A United Airlines passenger plane arrives over residential buildings to land at Heathrow Airport in west London, United Kingdom, on March 13, 2020.

Matthew Childs | Reuters

The CEOs of several major US and UK airlines on Tuesday increased pressure on their respective governments to revitalize air travel between the two countries and called for a summit to discuss the matter.

“Public health must guide the reopening of international air travel and we are confident that the aviation industry has the right tools, based on data and science, to enable a safe and meaningful restart of transatlantic travel,” it said the letter to US Secretary of Transportation Pete Buttigieg and his British counterpart Grant Shapps. “US and UK citizens would benefit from the extensive testing capabilities and successful trials of digital health data verification applications.”

The letter was signed by the CEOs of Delta Air Lines, United Airlines, American Airlines, British Airways, Virgin Atlantic and JetBlue Airways, who plan to start service between the US and the UK this summer, and the US industrial group Airlines for America.

Executives pointed out the surge in vaccinations and the economic benefits of reopening travel. The US is currently banning most non-US citizens or permanent residents traveling from the UK, while US visitors are subject to a 10-day quarantine when entering the UK

The US Department of Transportation and the United Kingdom Department of Transportation did not comment immediately.

Categories
Business

Vaccine ramp up most likely not sufficient to handle UK virus variant

An increase in vaccinations in the coming weeks alone may not be enough to contain the spread of a coronavirus variant, which was first reported in the UK in December and has now emerged in the US, said Scott Gottlieb, former commissioner for food and drug delivery.

The emergence of variants could complicate efforts to reopen the economy in the United States, which, according to Johns Hopkins University, had at least 475,000 virus deaths more than any other country.

The UK first reported the strain known as B117 to the World Health Organization in December, and now there are 971 cases in 37 US states, according to the Centers for Disease Control and Prevention.

“Right now they are shipping 11 million cans a week in states. That will likely increase,” said Gottlieb, who served as FDA chief under former President Donald Trump from 2017 to 2019, in CNBC’s “The News with Shepard Smith”. on Thursday. “So we’re increasing the vaccination rate across the country. Well, will it be fast enough to get a backstop against B117 – probably not by itself.”

Gottlieb said he doesn’t think travel restrictions could stop the spread of the B117 variant because it can often be too late. A “seasonal setback” in the form of the arrival of spring and summer could help reduce the spread of B117, said Gottlieb, a director of Pfizer, whose Covid vaccine is sold in the United States

He said that hopefully a combination of this and increasing vaccinations will include the variant in most parts of the country, although there may be hotspots in southern parts of California and Florida.

Categories
Business

U.S. may ramp up sluggish Covid vaccinations by giving two half doses of Moderna shot

A FDNY EMS Fire Department employee receives a COVID-19 Moderna vaccine amid the coronavirus disease (COVID-19) pandemic in the Manhattan neighborhood of New York City, New York, United States. December 23, 2020.

Carlo Allegri | Reuters

The head of the federal government’s Covid-19 vaccination program said Sunday that health officials are considering the idea of ​​giving a large group of Americans half-volume doses of a vaccine to speed up adoption.

Moncef Slaoui, head of Operation Warp Speed, said on CBS’s “Face the Nation” that one way to speed up immunization against Covid-19 is to give some people two half-volume doses of the Moderna vaccine.

“We know that for the Moderna vaccine, half the dose is given to people between the ages of 18 and 55 – two doses, half the dose, which is exactly the goal of getting twice the number of people using the doses immunize that we have – we know it induces an identical immune response to the 100 microgram dose, “Slaoui said.

“And that’s why we’re in talks with Moderna and the FDA – of course it will ultimately be a decision of the FDA – to accelerate the injection of half the volume,” he added.

Moncef Slaoui, a former executive director of GlaxoSmithKline, speaks to President Donald J. Trump during a vaccine development event in the Rose Garden of the White House on Friday, May 15, 2020 in Washington, DC.

Jabin Botsford | The Washington Post | Getty Images

The comments came in response to why the US is not adopting the strategy of giving all available vaccine doses now, even though the approved vaccines require a second round of firing to be fully effective. The UK has taken this approach in the hope that continued production will enable the second recordings in the future.

Slaoui said it was a mistake to make a decision that was not supported by the experimental data. White House Health Advisor Dr. Anthony Fauci, commented similarly on NBC’s Meet the Press on Sunday, said the strategy “goes against science” and would not solve the problems with the US launch.

“The idea of ​​expanding it so you can get more people is when you don’t have enough vaccine and a lot of people are waiting in line to wait for a vaccine,” Fauci said. “That’s not our problem now. We have a vaccine. We have to get it into people’s arms. It really is the right solution to the wrong problem.”

The FDA and Moderna did not immediately respond to requests for comment.

The dispute over different vaccination approaches stems from the fact that the introduction of the vaccine in the US did not achieve the goals of Operation Warp Speed ​​and the pandemic continues to devastate the country. President Donald Trump has blamed states for the slow adoption as the number of vaccinations given lags behind the number of vaccines sent and delivered.

Health officials wanted to inject a vaccine to 20 million Americans by the end of the year. However, according to the Centers for Disease Control and Prevention, only about 4.2 million people had received gunfire by January 2.

The last 7-day average for new cases of the coronavirus in the US is 205,093, according to John Hopkins University. That number has grown by 8% week-to-week, although tests and reports tended to be inconsistent during the holiday season. According to Johns Hopkins, the nation has an average of more than 2,600 deaths a day attributed to the virus.